Differential expression of BCL-2 oncoprotein and fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis

Haematologica

Volumn 81, Issue 4, 1996, Pages 302-309

  Molica, Stefano ^a   Mannella, Ada ^a   Dattilo, Angela ^a   Levato, Domenico ^a   Iuliano, Franceso ^a   Peta, Antonio ^a   Consarino, Caterina ^a   Magro, Saverio ^a  

^a PUGLIESE CIACCIO HOSPITAL   (Italy)

Author keywords

Bcl 2; Bone marrow leukemic cells; Fas Ag; Peripheral blood leukocytes

Indexed keywords

FAS ANTIGEN; PROTEIN BCL 2;

ACUTE LYMPHOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOPROLIFERATIVE DISEASE; MONOCYTE; NEUTROPHIL; NONLYMPHATIC LEUKEMIA; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANTIGENS, CD95; B-LYMPHOCYTES; BONE MARROW; FLOW CYTOMETRY; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES;

EID: 0030321241     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Korsmeyer SJ. Bcl-2 initiates new categories of oncogenes: regulators of cell death. Blood 1992, 80:879-86.
2. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75:1169-78.
3. Iwai K, Miyawaki T, Takizawa T, et al. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes and neutrophils. Blood 1994, 84:1201-8.
4. Knipping E, Debatin KM, Stricker K, Heilig B, Eder A, Krammer PH. Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T- cell leukemias. Blood 1995; 85:1562-9.
5. Zutter M, Hockenbery D, Silverman GA, Korsemeyer SJ. Immunolocalization of the bcl-2 protein within hematopoietic neoplasms. Blood 1991; 78:1062-8.
6. Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993; 151:621-7.
7. Yoshino T, Kondo E, Cao L, et al. Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 1994; 83:1856-61.
8. Kondo E, Yoshino T, Yamadori I, et al. Expression of bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas. Am J Pathol 1994; 145:330-7.
9. Bennet JM, Catowsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985; 103:626-34.
10. Bene M.C, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. Leukemia 1995; 9:1783-6.
11. Pizzolo G, Vincenzi C, Nadali G, et al. Detection of membrane and intracellular antigens by flow cytometry following ORTHO permeafix fixation. Leukemia 1994; 8:672-6.
12. Lavabre-Bertrand T, Duperray C, Brunet C, et al. Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: relevance for the study of B-cell neoplasias. Leukemia 1994; 8:402-8.
13. Molica S, Santoro R, Consarino C, et al. More on CD10-positive cells in bone marrow of children with immune thrombocytopenia. Haematologica 1994; 79:570-1.
14. Massaia M, Borrione P, Attisano C, et al. Dysregulated Fas and bcl-2 expression leading to enhanced apoptosis in T-cells of multiple myeloma patients. Blood 1995; 85:3679-87.
15. Lepelley P, Soenen V, Preudhomme C, et al. Bcl-2 expression in myelodysplatic syndromes and its correlation with hematological features, p53 mutations and prognosis. Leukemia 1995; 9:726-30.
16. Campos L, Rouault JP, Sabido O, et al. High expression of bcl-2 protein in acute myeloid lekemia cells is associated with poor response to chemotherapy. Blood 1993; 81:3091-6.
17. Delia D, Aiello A, Soligo D, et al. Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 1992; 79:1291-8.
18. Porwit-MacDonald A, Ivory K, Wilkinson S, Weatley K, Wong L, Ianossy G. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia. Leukemia 1995; 9:1191-8.
19. Bensi L, Longo R, Vecchi A, et al. Bcl2 oncoprotein expression in acute myeloid leukemia. Haematologica 1995; 80:98-102.
20. Min YK, Lee S, Chong SY, Hahn JS, Ko YW. High expression of Fas and bcl2/CD34 in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1995; 86 (Suppl. 1):40a.
21. Del Poeta G, Venditti A, Stasi R, et al. High levels of bcl2 protein do not affect prognosis in acute myeloid leukemia (AML). Blood 1995; 86 (Suppl. 1)41a.
22. Guyonat D, Sebban C, Berthlas MF, et al. Significance of bcl2 proto-oncogene expression in adult acute lymphoblastic leukemia cells. Blood 1995, 86 (Suppl.1):761a.
23. + human marrow cells is induced by interferon and tumor necrosis factor and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995; 11:3183-90.
24. Nagafuji K, Shibuya J, Harade M, et al. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 1995; 83:883-9.
25. Coustan-Smith E, Kitanaka A, Pui CH. Clinical relevance of bcl-2 overexpression in childhood acute lymphoblastic leukemia. Blood 1996; 87:1140-6.
26. Schena M, Larsson LG, Gottardi D, et al. Growth and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 1992; 79:2981-9.
27. Hanada M, Delia D, Aiello A, Stadmauer E, Reed JC. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993; 82:1820-8.
28. Mapara MY, Bargou R, Zugck C, et al. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur J Immunol 1993; 23:702-8.
29. Panayiotidis P, Ganeshaguru K, Foroni L, Hoffbrand AV. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia. Leukemia 1995; 9:1227-32.
30. Pozzato G, de Paoli P, Franzin F, et al. Effects of α-interferon and steroids on CD23 expression and release in B-cell chronic lymphocytic leukemia. Haematologica 1994; 79:205-12.
31. Gruss HJ, Dower SK. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 1995; 85:3378-404.
32. Miyashita T, Reed JC. bcl-2 oncoprotein blocks chemotherapy induced apoptosis in a human leukemia cell line. Blood 1993; 81:151-7.